{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:05:05Z","timestamp":1780484705687,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Chongqing Medical and health science and technology","award":["2017CQ323"],"award-info":[{"award-number":["2017CQ323"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.cbi.2020.109088","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T21:40:33Z","timestamp":1588282833000},"page":"109088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The GPR55 antagonist CID16020046 mitigates advanced glycation end products (AGEs)- induced chondrocyte activation"],"prefix":"10.1016","volume":"325","author":[{"given":"Yong","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingqin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.cbi.2020.109088_bib1","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/annrheumdis-2013-204763","article-title":"The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.cbi.2020.109088_bib2","doi-asserted-by":"crossref","first-page":"16072","DOI":"10.1038\/nrdp.2016.72","article-title":"Osteoarthritis","volume":"13","author":"Martel-Pelletier","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"10.1016\/j.cbi.2020.109088_bib3","doi-asserted-by":"crossref","first-page":"26035","DOI":"10.3390\/ijms161125943","article-title":"Chondrocyte apoptosis in the pathogenesis of osteoarthritis","volume":"16","author":"Hwang","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.cbi.2020.109088_bib4","doi-asserted-by":"crossref","first-page":"20560","DOI":"10.3390\/ijms160920560","article-title":"Biomarkers of chondrocyte apoptosis and autophagy in osteoarthritis","volume":"16","author":"Hwang","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2020.109088_bib5","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.biopha.2017.07.034","article-title":"Research progress on osteoarthritis treatment mechanisms","volume":"93","author":"Gu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2020.109088_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2017.02.030","article-title":"Advanced glycation end-products produced systemically and by macrophages: a common contributor to inflammation and degenerative diseases","volume":"177","author":"Byun","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.cbi.2020.109088_bib7","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/art.21199","article-title":"Articular chondrocytes express the receptor for advanced glycation end products: potential role in osteoarthritis","volume":"52","author":"Loeser","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cbi.2020.109088_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/fcp.12094","article-title":"Advanced glycation end products-induced chondrocyte apoptosis through mitochondrial dysfunction in cultured rabbit chondrocyte","volume":"29","author":"Yang","year":"2015","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.cbi.2020.109088_bib9","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s10495-016-1280-z","article-title":"Pioglitazone inhibits advanced glycation end product-induced matrix metalloproteinases and apoptosis by suppressing the activation of MAPK and NF-\u03baB","volume":"21","author":"Zhang","year":"2016","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.cbi.2020.109088_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/art.21523","article-title":"Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes","volume":"54","author":"Steenvoorden","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.cbi.2020.109088_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-328X(98)00277-0","article-title":"Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain","volume":"64","author":"Sawzdargo","year":"1999","journal-title":"Brain Res Mol Brain Res"},{"issue":"20","key":"10.1016\/j.cbi.2020.109088_bib12","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2174\/0929867323666160425113836","article-title":"Advances towards the discovery of GPR55 ligands","volume":"23","author":"Morales","year":"2016","journal-title":"Curr. Med. Chem."},{"issue":"5\u20136","key":"10.1016\/j.cbi.2020.109088_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000493490","article-title":"Structure-activity relationship of the GPR55 antagonist, CID16020046","volume":"102","author":"Brown","year":"2018","journal-title":"Pharmacology"},{"issue":"3","key":"10.1016\/j.cbi.2020.109088_bib14","first-page":"459","article-title":"The GPR55 antagonist CID16020046 protects against intestinal inflammation","volume":"39","author":"Stan\u010di\u0107","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cbi.2020.109088_bib15","series-title":"The LPI\/GPR55 axis Enhances Human Breast Cancer Cell Migration via HBXIP and P-MLC Signaling","first-page":"459","volume":"vol. 39","author":"Zhou","year":"2018"},{"issue":"1","key":"10.1016\/j.cbi.2020.109088_bib16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12974-018-1362-7","article-title":"Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells","volume":"15","author":"Saliba","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"Suppl 2","key":"10.1016\/j.cbi.2020.109088_bib17","article-title":"Expression of cannabinoid receptors by human articular chondrocytes","volume":"48","author":"Andersson","year":"2011","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.cbi.2020.109088_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/can.2015.0001","article-title":"Expression of cannabinoid receptors in human osteoarthritic cartilage: implications for future. Therapies","volume":"1","author":"Dunn","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"10.1016\/j.cbi.2020.109088_bib19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/nyas.13407","article-title":"Oxidative stress and chronic inflammation in osteoarthritis: can NRF2 counteract these partners in crime?","volume":"1401","author":"Marchev","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.cbi.2020.109088_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/rheumatology\/kem376","article-title":"Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes","volume":"47","author":"Nah","year":"2008","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.cbi.2020.109088_bib21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00002281-200309000-00017","article-title":"Role of eicosanoids in structural degradation in osteoarthritis","volume":"15","author":"Laufer","year":"2003","journal-title":"Curr. Opin. Rheumatol."},{"issue":"6","key":"10.1016\/j.cbi.2020.109088_bib22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11926-000-0019-5","article-title":"COX-2, NO, and cartilage damage and repair","volume":"2","author":"Amin","year":"2000","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.cbi.2020.109088_bib23","doi-asserted-by":"crossref","first-page":"4895050","DOI":"10.1155\/2016\/4895050","article-title":"A tale of two joints: the role of matrix metalloproteases in cartilage biology","volume":"2016","author":"Rose","year":"2016","journal-title":"Dis. Markers"},{"issue":"Suppl 1","key":"10.1016\/j.cbi.2020.109088_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/rmdopen-2015-000061","article-title":"Pathophysiology of osteoarthritis: canonical NF-\u03baB\/IKK\u03b2-dependent and kinase-independent effects of IKK\u03b1 in cartilage degradation and chondrocyte differentiation","volume":"1","author":"Olivotto","year":"2015","journal-title":"RMD Open"},{"issue":"10","key":"10.1016\/j.cbi.2020.109088_bib25","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1210\/js.2019-00160","article-title":"Advanced glycation end products (AGEs), receptor for AGEs, diabetes, and bone: review of the literature","volume":"3","author":"Asadipooya","year":"2019","journal-title":"J Endocr Soc"},{"issue":"5","key":"10.1016\/j.cbi.2020.109088_bib26","first-page":"48","article-title":"Danger signals and inflammaging in osteoarthritis","volume":"37","author":"Millerand","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"23","key":"10.1016\/j.cbi.2020.109088_bib27","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1111\/bph.12850","article-title":"Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling","volume":"171","author":"Balenga","year":"2014","journal-title":"Br. J. Pharmacol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719316114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719316114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:47:33Z","timestamp":1762112853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279719316114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":27,"alternative-id":["S0009279719316114"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2020.109088","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The GPR55 antagonist CID16020046 mitigates advanced glycation end products (AGEs)- induced chondrocyte activation","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2020.109088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109088"}}